Clofibrate-induced increase in serum-creatine-phosphokinase level.
D002994:Clofibrate / Q000627:therapeutic use / Q000633:toxicity*; D003402:Creatine Kinase / Q000097:blood*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy / Q000201:enzymology; D008297:Male; D008875:Middle Aged
D003402:Creatine Kinase; D002994:Clofibrate